Thus, to investigate whether the mechanism by which β-elemene reverses drug resistance to cisplatin involves, at least in part, the inhibition of DNA repair activity, we tested the effect of β-elemene on cisplatin-upregulated ERCC-1 expression in resistant ovarian cancer cells. This evidence concerns the gene ERCC1 and ovarian carcinoma.